@ryanvpharmd.bsky.social @brainofbpharm.bsky.social: This study evaluated the impact of a guidance document on treatment decisions, clinical outcomes for CRAB, Steno. Our results demonstrate that implementing a treatment guideline may ⬆️ guideline directed treatment. doi.org/10.1017/ash....

VUMC 🏥 is recruiting for a PGY2 ID Pharmacy resident 🧫🦠 next year! If you or someone you know is interested, come check out one of our virtual open house sessions. We have an amazing team of 4 inpatient, 2 OPAT, 1 peds, and 1 HIV pharmacists (and more) to work with!

‼️Just shared at #IDWeek2025 & now published in @ofidjournal.bsky.social cephalexin vs. cefdinir for tx of uUTI in females. Spoiler: Cefdinir was independently associated with/failure & cefdinir pts were twice as likely to fail. Let’s stop Rx’ing cefdinir for UTI! 🛑💊 academic.oup.com/ofid/article...

Finally published 🆕🔥DOTS RCT Among participants with complicated S aureus bacteremia who achieved blood culture clearance, dalbavancin was not superior to standard therapy for achieving a more desirable outcome at day 70 #idsky jamanetwork.com/journals/jam...

What’s the optimal cefazolin dose for MSSA CNS infections? New PK/PD data says: it’s not just about higher doses—MIC matters. 2g q6h works only if MIC <=0.5 mg/L For MIC:1-2 mg/L, continuous infusion (10–12g/day) may be needed to hit PD targets #idsky journals.asm.org/doi/10.1128/...

The SNAP trial may finally resolve some of the longest-running debates in SAB management (cefazolin vs semi-synthetic PCN? Is PCN really active vs PSSA?). Huge congrats to Drs. Joshua Davis, Steven Tong, & the global team who made this ambitious trial happen. #IDSky blogs.jwatch.org/hiv-id-obser...

The entire archive of CDC datasets can be found here. HUGE shoutout to data archivists- this work is important 👏🙌🏻 archive.org/details/2025...

📋👀 Did you miss any of these articles from 2024? 📲 www.idstewardship.com/year-review-... #IDsky with @absteward.bsky.social